ScoreWhy is Nurix Therapeutics, Inc. ?
1
Flat results in Nov 25
- OPERATING CASH FLOW(Y) Lowest at USD -249.46 MM
- NET SALES(Q) At USD 13.58 MM has Fallen at -35.11%
- PRE-TAX PROFIT(Q) At USD -78.22 MM has Fallen at -28.22%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 5.64%, its profits have fallen by -36.6%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Nurix Therapeutics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Nurix Therapeutics, Inc.
5.64%
-0.09
66.87%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
36.35%
EBIT Growth (5y)
-219.10%
EBIT to Interest (avg)
-164.05
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.07
Sales to Capital Employed (avg)
0.22
Tax Ratio
0.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
94.17%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.94
EV to EBIT
-3.47
EV to EBITDA
-3.72
EV to Capital Employed
-19.30
EV to Sales
11.81
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-49.09%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET PROFIT(HY)
Higher at USD -164.64 MM
ROCE(HY)
Highest at -49.63%
NET SALES(9M)
Higher at USD 65.53 MM
-17What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -249.46 MM
NET SALES(Q)
At USD 13.58 MM has Fallen at -35.11%
PRE-TAX PROFIT(Q)
At USD -78.22 MM has Fallen at -28.22%
NET PROFIT(Q)
At USD -78.22 MM has Fallen at -27.82%
Here's what is not working for Nurix Therapeutics, Inc.
Net Sales
At USD 13.58 MM has Fallen at -35.11%
over average net sales of the previous four periods of USD 20.92 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Operating Cash Flow
Lowest at USD -249.46 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Pre-Tax Profit
At USD -78.22 MM has Fallen at -28.22%
over average net sales of the previous four periods of USD -61 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -78.22 MM has Fallen at -27.82%
over average net sales of the previous four periods of USD -61.2 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
